MedTech-related health technology assessments from NIHR in September 2022

The National Institute for Health Research (NIHR) funds valuable independent research for health and social care decision-makers in England. Reports from the Health Technology Assessment (HTA) Programme are published in the NIHR HTA Journal and inform NICE guidance.

In September 2022, one MedTech-related assessment was published in the NIHR HTA Journal:

• Early computed tomography coronary angiography in adults presenting with suspected acute coronary syndrome, based on a prospective, multicenter, open, parallel-group randomized controlled trial with blinded end-point adjudication (RAPID-CTCA). Early computed tomography coronary angiography (CTCA), in addition to standard care, was compared with standard care alone. Participants were followed up for one year. This study showed that CTCA did not alter one-year all-cause death or subsequent myocardial infarction, but it did increase the length of hospital stay and healthcare cost. These findings do not support the routine use of early computed tomography coronary angiography in intermediate-risk patients with acute chest pain.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).